Correlation Between Syndax Pharmaceuticals and AbbVie
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and AbbVie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and AbbVie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and AbbVie Inc, you can compare the effects of market volatilities on Syndax Pharmaceuticals and AbbVie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of AbbVie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and AbbVie.
Diversification Opportunities for Syndax Pharmaceuticals and AbbVie
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Syndax and AbbVie is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and AbbVie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AbbVie Inc and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with AbbVie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AbbVie Inc has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and AbbVie go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and AbbVie
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 5.85 times less return on investment than AbbVie. In addition to that, Syndax Pharmaceuticals is 3.8 times more volatile than AbbVie Inc. It trades about 0.02 of its total potential returns per unit of risk. AbbVie Inc is currently generating about 0.45 per unit of volatility. If you would invest 19,014 in AbbVie Inc on December 5, 2024 and sell it today you would earn a total of 1,762 from holding AbbVie Inc or generate 9.27% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Syndax Pharmaceuticals vs. AbbVie Inc
Performance |
Timeline |
Syndax Pharmaceuticals |
AbbVie Inc |
Syndax Pharmaceuticals and AbbVie Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Syndax Pharmaceuticals and AbbVie
The main advantage of trading using opposite Syndax Pharmaceuticals and AbbVie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, AbbVie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will offset losses from the drop in AbbVie's long position.Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
AbbVie vs. Merck Company | AbbVie vs. Pfizer Inc | AbbVie vs. Eli Lilly and | AbbVie vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |